The role of galectin‐3 in heart failure and cardiovascular disease

Summary Galectin‐3, a β‐galactoside‐binding lectin, is a new important player in the progression of heart failure (HF) and is also linked to poor outcome in patients with cardiovascular disease. Genetic or pharmacological inhibition of galectin‐3 slows down the progression of myocardial inflammation...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical and experimental pharmacology & physiology 2019-03, Vol.46 (3), p.197-203
Hauptverfasser:	Zhong, Xiao, Qian, Xiaoqian, Chen, Guangping, Song, Xiang
Format:	Artikel
Sprache:	eng
Schlagworte:	aldosterone angiotenin II Animals Cardiovascular disease Cardiovascular diseases Collagen Congestive heart failure Coronary artery disease Fibrosis Galectin 3 - metabolism galectin‐3 Health risks Heart failure Heart Failure - diagnosis Heart Failure - metabolism Heart Failure - pathology Heart Failure - therapy Humans Medical treatment Pharmacology Risk Assessment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!